Publications by authors named "Hisashi Matsubara"

MIRAgel is a hydrogel buckle material that was widely used for scleral implantation surgery in the past. However, postoperative complications such as conjunctival hyperemia and impaired eye movements were reported due to postoperative expansion of the MIRAgel buckle. In addition, damage to the sclera due to hydrolysis of the MIRAgel buckle has been reported.

View Article and Find Full Text PDF
Article Synopsis
  • Anti-VEGF therapy is the main treatment for neovascular age-related macular degeneration (nvAMD), and this study investigates factors influencing visual outcomes for treated patients.
  • Conducted in Japan with 182 elderly patients, the study examines how age, baseline vision, and eye conditions affect visual acuity after one year of treatment with ranibizumab or aflibercept.
  • Key findings reveal that younger age, absence of intraretinal fluid and pigment epithelial detachment, and lack of smoking or diabetes history can lead to better visual prognosis in nvAMD patients.
View Article and Find Full Text PDF
Article Synopsis
  • The study examined how flicker electroretinogram (ERG) amplitudes changed in 20 patients after combined cataract surgery and vitrectomy for idiopathic epiretinal membrane (ERM).
  • Significant increases in flicker ERG amplitudes were observed 1 week post-surgery, but these levels gradually declined, returning to baseline by 6 months.
  • Additionally, central macular thickness (CMT) decreased significantly after the surgery, indicating that early functioning assessments may help predict the long-term outcomes of the ERM treatment.
View Article and Find Full Text PDF

To develop a machine learning logistic regression algorithm that can classify patients with an idiopathic macular hole (IMH) into those with good or poor vison at 6 months after a vitrectomy. In addition, to determine its accuracy and the contribution of the preoperative OCT characteristics to the algorithm. This was a single-center, cohort study.

View Article and Find Full Text PDF

To determine the recurrence rate of neovascular age-related macular degeneration (nAMD) during a 5-year period after the suspension of anti-vascular endothelial growth factor (anti-VEGF) treatments. Thirty-four eyes of 34 nAMD patients who met the inclusion criteria and were treated by anti-VEGF drugs were studied. All met the treatment suspension criteria and were followed for 5 years after the suspension of the anti-VEGF treatment.

View Article and Find Full Text PDF

Background: The purpose of this study was to develop a model that can predict the postoperative visual acuity in eyes that had undergone vitrectomy for an epiretinal membrane (ERM). The Light Gradient Boosting Machine (LightGBM) was used to evaluate the accuracy of the prediction and the contribution of the explanatory variables. Two models were designed to predict the postoperative visual acuity in 67 ERM patients.

View Article and Find Full Text PDF
Article Synopsis
  • Indolent nonprogressive multifocal choroidal lesions are benign growths in the eye that don’t impact visual function, but their effects on retinal circulation and function were previously unclear.
  • A 45-year-old male patient was studied, exhibiting multiple well-defined lesions seen through optical coherence tomography (OCT), which revealed no blood flow within the lesions and reduced circulation above them.
  • Testing showed that, despite some retinal pigment epithelial damage, overall retinal function remained normal, suggesting that while these lesions don't harm vision, monitoring retinal health is important.
View Article and Find Full Text PDF

In electroretinographic (ERG) recordings of zebrafish, the light stimulus is usually delivered by a fiber optic cable. The purpose of this study was to determine whether the angle of incidence of the stimulus light from the fiber optic cable will affect the amplitudes and implicit times of the ERGs of zebrafish larvae. The larvae were positioned on their side with the right eye pointed upward.

View Article and Find Full Text PDF

A choroidal osteoma (CO) is a relatively rare, benign tumor with ossification that develops in the choroid and undergoes enlargement and decalcification in its natural course. Photodynamic therapy (PDT) is used to induce decalcification, but there are few reports on individual cases treated with PDT. A 47-year-old Japanese man who had reduced decimal visual acuity (VA) of the right eye to 0.

View Article and Find Full Text PDF

Rationale: Acute retinal necrosis (ARN) was first reported in 1971 by Urayama et al as an acute uveitis accompanied by retinal arteritis and white retinal lesions in the peripheral retina that can progress to a rhegmatogenous retinal detachment (RRD). We have experienced a case of ARN that, unlike the common developmental course to an RRD associated with ARN, progressed to proliferative vitreoretinopathy (PVR) involving the entire retina in 2 days. The purpose of this report is to present our findings in the case of ARN with an atypical rapid time course.

View Article and Find Full Text PDF

Intraocular inflammations (IOIs) have been reported to occur after intravitreal injections of brolucizumab, and one of their causes has been suggested to be drug-specific features. We evaluated the anterior chamber by the aqueous flare value (AFV) and the retina by flicker electroretinography (ERG) after the initial intravitreal injection of aflibercept (IVA), brolucizumab (IVBr), or faricimab (IVF) for neovascular age-related macular degeneration (nAMD). The AFV and flicker ERGs were determined before, 2 weeks after, and 4 weeks after the injections in 14 eyes of 14 patients for each drug.

View Article and Find Full Text PDF

: Brolucizumab (IVBr) is a recently introduced anti-vascular endothelial growth factor (anti-VEGF) which has been found to be very effective in treating neovascular age-related macular degeneration (nAMD). We reported our findings in a case of nAMD that developed intraocular inflammation (IOI) after IVBr injections. : A 79-year-old man was referred to our hospital complaining of reduced vision in both eyes of one-month's duration.

View Article and Find Full Text PDF

Epiretinal membrane (ERM) foveoschisis is a recently proposed clinical entity. The purpose of this study was to compare the clinical characteristics and surgical outcomes of eyes with ERM foveoschisis to those of typical ERM. The medical records of all patients with ERM-related disorders examined between 2011 and 2020 were reviewed.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to investigate whether stopping anti-VEGF treatment affects retinal pigment epithelium (RPE) atrophy in patients with neovascular age-related macular degeneration (nAMD).
  • Twelve patients were divided into two groups: one continued treatment and the other suspended it, with RPE atrophy measured over a year.
  • Results showed no significant difference in the rate of RPE atrophy between the continuation and suspension groups, indicating treatment suspension does not impact atrophy progression.
View Article and Find Full Text PDF

Purpose: Neovascular age-related macular degeneration (nAMD) is classified into typical AMD (tAMD), polypoidal choroidal vasculopathy (PCV), and retinal angiomatous proliferation (RAP). This study investigated clinical features of the 3 subtypes and visual outcome associated with treatment regimens in a large cohort of patients with nAMD in a clinical setting.

Design: Retrospective multicenter cohort study.

View Article and Find Full Text PDF

Introduction: The aim of this study was to determine whether the use of perfluorocarbon liquid (PFCL) affects the rate of retinal re-attachments after an initial attachment by vitrectomy in eyes with rhegmatogenous retinal detachment (RRD).

Methods: This was a retrospective, observational, multicenter study of 3,446 eyes registered in the Japanese vitreoretinal surgery treatment information database. Of these, 2,648 eyes had undergone vitrectomy as the first surgery for RRD.

View Article and Find Full Text PDF

Purpose: To investigate age-specific prevalence of disease subtypes and baseline best-corrected visual acuity (BCVA) in Japanese patients with treatment-naïve neovascular age-related macular degeneration (nAMD).

Study Design: Retrospective multicenter case series.

Methods: We reviewed the records of patients with treatment-naïve nAMD who underwent initial treatment in 14 institutions in Japan sometime during the period from 2006 to 2015.

View Article and Find Full Text PDF

Rationale: Multiple evanescent white dot syndrome (MEWDS) is characterized by multiple white dots in the posterior pole of the eye, but its diagnosis can be difficult in cases when the white dots are not visible. We report an atypical case of MEWDS that developed in pathologic myopia.

Patient Concern: A 42-year-old woman presented with floater and reduced and distorted vision in the right eye that she noted 3 days earlier.

View Article and Find Full Text PDF

Purpose: To determine the mechanism for the development of segmental granular lesions along the retinal vessels in eyes with acute retinal necrosis.

Method: This was a retrospective analysis of the medical records of three eyes of three patients who were diagnosed with acute retinal necrosis that had atypical segmental granular lesions aligned along the retinal vessels.

Results: The segmental granular lesions were present on the retinal arteries and veins throughout the retina.

View Article and Find Full Text PDF

Purpose: To determine the characteristics and cause of the increase in the amplitude of flicker electroretinography (ERG) after cataract surgery.

Design: Prospective, observational clinical study.

Participants: Thirty patients who underwent cataract surgery.

View Article and Find Full Text PDF

The development of a full-thickness macular hole (FTMH) is a rare complication of intravitreal injections, and only a small subset of eyes with an FTMH has a spontaneous closure. We report a case of repeated FTMH formations and a spontaneous closure following an intravitreal injection of bevacizumab (IVB) for a central retinal vein occlusion (CRVO). A 39-year-old male patient presented with reduced vision in his right eye and was diagnosed with a CRVO.

View Article and Find Full Text PDF

Anti-vascular endothelial growth factor (VEGF) therapy for diabetic macular edema (DME) improves visual acuity. However, repeated injections during routine outpatient visits are required to maintain this effect. The recent sudden global outbreak of coronavirus disease 2019 (COVID-19) had a major impact on daily life, including medical care, such as the provision of VEGF therapy.

View Article and Find Full Text PDF

Purpose: To determine whether the response to the initial anti-vascular endothelial growth factor (anti-VEGF) injection to treat diabetic macular edema (DME) is significantly correlated with the response to the third consecutive monthly injection of the same anti-VEGF agent. Methods: Seventy eyes with DME that were treated with an anti-VEGF agent (16 eyes with 1.25-mg bevacizumab, 35 eyes with 0.

View Article and Find Full Text PDF

Purpose: To evaluate the clinical characteristics, treatment trends, and visual prognosis of submacular hemorrhage (SMH) secondary to neovascular age-related macular degeneration (nAMD) and retinal arterial macroaneurysm (RAM).

Methods: This retrospective study enrolled 187 Japanese patients with SMH at 10 institutions from 2015 to 2018. Medical records including SMH etiology, best-corrected visual acuity (BCVA), fundus photographs, optical coherence tomography images, and selected treatments were analyzed.

View Article and Find Full Text PDF

Purpose: To compare the therapeutic effects of anti-vascular endothelial growth factor (anti-VEGF) agents in eyes with macular edema associated with branch retinal vein occlusion (BRVO-ME) with glaucoma to those without glaucoma.

Patients And Methods: This retrospective study was conducted using the medical records of Mie University Hospital from 2013 to 2017. Patients were recruited if they had received anti-VEGF agents for BRVO-ME treatment and included 30 patients (30 eyes) without glaucoma (G[-] group) and 27 patients (27 eyes) with glaucoma (G[+] group).

View Article and Find Full Text PDF